Early research (Phase 1)Ended earlyNCT05442580What this trial is testingCART-38 in Adult AML and MM PatientsWho this might be right forAcute Myeloid Leukemia (AML)Multiple Myeloma (MM) University of Pennsylvania 11
Very early researchActive Not RecruitingNCT05302648What this trial is testingTo Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MMWho this might be right forMultiple Myeloma Hrain Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT01413568What this trial is testingSafety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more Polyphor Ltd. 38
Not applicableStudy completedNCT03406091What this trial is testingDetection of Poor Mobilizer (PM) in Multiple Myeloma (MM) PatientsWho this might be right forMultiple Myeloma Fondazione EMN Italy Onlus 300
Testing effectiveness (Phase 2)Study completedNCT01166113What this trial is testingPomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to LenalidomideWho this might be right forMultiple Myeloma Fondazione EMN Italy Onlus 67
Testing effectiveness (Phase 2)Study completedNCT02703779What this trial is testingExploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Siddhartha Ganguly 101
Early research (Phase 1)Looking for participantsNCT05927571What this trial is testingA Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)Who this might be right forRelapsed or Refractory Multiple Myeloma Genentech, Inc. 120
Early research (Phase 1)Looking for participantsNCT06623630What this trial is testingLymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal FunctionWho this might be right forMultiple Myeloma Washington University School of Medicine 16
Not applicableUnknownNCT05088330What this trial is testingAccess of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MMWho this might be right forNewly Diagnosed Multiple Myeloma The First Affiliated Hospital of Soochow University 76
Early research (Phase 1)Study completedNCT03106428What this trial is testingA Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological MalignanciesWho this might be right forAcute Myeloid LeukemiaMultiple MyelomaDiffuse Large B-cell Lymphoma MedImmune LLC 67
Not applicableLooking for participantsNCT05361694What this trial is testingTwo Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor ConditionsWho this might be right forMultiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance University of Miami 1,000
Not applicableNot Yet RecruitingNCT07558057What this trial is testingCognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX StudyWho this might be right forMalignant Lymphoma - LymphoplasmacyticMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Aarhus University Hospital 225
Not applicableLooking for participantsNCT05879757What this trial is testingReal-world Usage of HyQvia in Multiple Myeloma Adults With Secondary ImmunodeficiencyWho this might be right forMultiple MyelomaSecondary Immunodeficiency (SID) Takeda 75
Early research (Phase 1)Looking for participantsNCT07280013What this trial is testingLearn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsWho this might be right forMultiple Myeloma (MM) C4 Therapeutics, Inc. 60
Not applicableActive Not RecruitingNCT07088783What this trial is testingMobile App Education Based on Orem's Self-Care Model in Multiple Myeloma PatientsWho this might be right forMultiple Myeloma (MM)Self-careQuality of Life Ozlem 60
Testing effectiveness (Phase 2)Looking for participantsNCT06953960What this trial is testingAssess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)Who this might be right forMultiple Myeloma AbbVie 325
Not applicableLooking for participantsNCT07342179What this trial is testingCAR-T Immunomonitoring in Multiple Myeloma (CART I5M)Who this might be right forMultiple Myeloma (MM) Poitiers University Hospital 60
Not applicableLooking for participantsNCT07782944What this trial is testingCD38 Targeted -PET/ CT for Multiple MyelomaWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Guilin Medical University, China 100
Testing effectiveness (Phase 2)Study completedNCT01857115What this trial is testingStudy of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)Who this might be right forMultiple Myeloma European Myeloma Network B.V. 63
Not applicableNo Longer AvailableNCT00720603What this trial is testingThis is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.Who this might be right forNon-Hodgkin's LymphomaHodgkin's DiseaseMultiple Myeloma Genzyme, a Sanofi Company